CHI3L1 and liver dysplastic nodule: We performed sensitivity analysis by excluding the study of Rondbjerg et al. from the meta-analysis concerning the YKL-40 biomarker, as the categorization of DN patients was slightly different from the ones described in the rest of the studies and may have potentially biased the categorization of the T2DM patients with DN.